| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.31% |
| NAV | ₹11.10 (06 Aug 2020) |
|---|---|
| Fund Started | 27 Jul 2018 |
| Fund Size | ₹150 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Hindustan Unilever Ltd. | FMCG | Equity | 8.4% |
| HDFC Bank Ltd. | Financial | Equity | 6.6% |
| Reliance Industries Ltd. | Energy | Equity | 6.1% |
| Avenue Supermarts Ltd. | Services | Equity | 4.9% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.5% |
| Lupin Ltd. | Healthcare | Equity | 3.8% |
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 3.8% |
| Dabur India Ltd. | FMCG | Equity | 3.8% |
| Dhanuka Agritech Ltd. | Chemicals | Equity | 3.5% |
| Bharti Airtel Ltd. | Communication | Equity | 3.3% |
IDFC Equity Opportunity Series 6 Regular Growth is a Equity Mutual Fund Scheme launched by IDFC Mutual Fund. This scheme was made available to investors on 27 Jul 2018. Anoop Bhaskar, Sumit Agrawal, Kartik Mehta is the Current Fund Manager of IDFC Equity Opportunity Series 6 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹150 Cr and the Latest NAV as of 06 Aug 2020 is ₹11.10.
The IDFC Equity Opportunity Series 6 Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The Scheme seeks to generate capital appreciation from a portfolio that is invested in equity and equity related securities of companies across market capitalization that will benefit from growth of the Indian and the global economy and in Debt and Money Market instruments maturing on or before the maturity of the scheme.